14 days of Premium, free.
Every scanner with live hit rates + the Market Pulse risk flag that tells you when to get defensive. No card required.
Start trial →
Tradestie Institutional Equity Comparison Engine · Market Close Nov 16, 2026
ARM vs MCHPP: Which Stock Is the Better Buy Now?
Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.
ARM Wins Head-to-Head Institutional Verdict (3–3 across 6 Pillars · 4–5 Matrix Metrics)
ARM Overall Winner
6-Pillar Tally: ARM 3 – 3 MCHPP
Matrix Metrics: ARM 4 – 5 MCHPP
As of Nov 16, 2026, Arm Holdings plc (ARM) is the stronger overall head-to-head candidate over Microchip Technology Incorporated Depositary Shares Each Representing a 1/20th Interest in a Share of 7.50% Series A Mandatory Convertible Preferred Stock (MCHPP) in the Tradestie Institutional Equity Comparison Engine, winning 4–5 core matrix metrics and 3–3 across our 6-pillar institutional scorecard (led by Valuation Multiples, Options & Positioning, R&D & Supply-Chain Moat). ARM carries a Unified Composite Score of 54.3/100 (HOLD) at $177.10 (89.1x Forward P/E, 17.0% operating margin), whereas MCHPP carries 57.1/100 (HOLD) at $52.64 (N/M Forward P/E, 21.6% operating margin).
Composite vs. Pillar Nuance: While MCHPP currently prints a higher short-term Unified Composite Score (57.1/100 HOLD vs. ARM 54.3/100 HOLD), ARM captures the overall institutional head-to-head verdict (4–5 matrix metrics and 3–3 across the 6 pillars) due to superior fundamental profitability (17.0% vs. 21.6% operating margin) and revenue trajectory (+27.1% vs. +42.2% YoY).
Technical & Structure Timing Caution: ARM is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average and Breakdown options structure phase (RSI 36.8); meanwhile MCHPP is in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 32.3). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.
Microchip Technology Incorporated Depositary Shares Each Representing a 1/20th Interest in a Share of 7.50% Series A Mandatory Convertible Preferred Stock
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on ARM vs MCHPP. Trailing 12-month operating profitability (ARM 17.0% vs MCHPP 21.6%) and valuation multiples (ARM 89.1x vs MCHPP N/M Forward P/E) are benchmarked directly in Pillar 4 below.
Investor FAQ ARM vs MCHPP Key Questions & Quantitative Answers
As of Nov 16, 2026, Arm Holdings plc (ARM) is the stronger overall head-to-head candidate over Microchip Technology Incorporated Depositary Shares Each Representing a 1/20th Interest in a Share of 7.50% Series A Mandatory Convertible Preferred Stock (MCHPP) in the Tradestie Institutional Equity Comparison Engine, winning 4–5 core matrix metrics and 3–3 across our 6-pillar institutional scorecard (led by Valuation Multiples, Options & Positioning, R&D & Supply-Chain Moat). ARM carries a Unified Composite Score of 54.3/100 (HOLD) at $177.10 (89.1x Forward P/E, 17.0% operating margin), whereas MCHPP carries 57.1/100 (HOLD) at $52.64 (N/M Forward P/E, 21.6% operating margin). Composite vs. Pillar Nuance: While MCHPP currently prints a higher short-term Unified Composite Score (57.1/100 HOLD vs. ARM 54.3/100 HOLD), ARM captures the overall institutional head-to-head verdict (4–5 matrix metrics and 3–3 across the 6 pillars) due to superior fundamental profitability (17.0% vs. 21.6% operating margin) and revenue trajectory (+27.1% vs. +42.2% YoY). Technical & Structure Timing Caution: ARM is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average and Breakdown options structure phase (RSI 36.8); meanwhile MCHPP is in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 32.3). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.
MCHPP leads the Growth & Scale pillar: ARM posts +27.1% YoY revenue growth and -45.5% YoY earnings growth on $5.46B TTM revenue (97.4% gross margin, 17.0% operating margin), compared with MCHPP at +42.2% YoY revenue growth and N/A YoY earnings growth on $5.60B TTM revenue (62.7% gross margin, 21.6% operating margin). On trailing 12-month operating scale, ARM generates $5.46B in USD-normalized revenue versus $5.60B for MCHPP. In operating R&D and SG&A reinvestment, ARM deploys 80.4% of Rev ($4.39B) (0 90-day corporate R&D disclosures) versus 41.1% of Rev ($2.30B) (0 disclosures) for MCHPP.
ARM screens cheaper on headline valuation multiples. ARM trades at 89.1x Forward P/E, N/M Trailing P/E, 1.68x PEG, and 38.6x EV/Revenue (21.5% FCF margin), whereas MCHPP trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and N/M EV/Revenue (33.3% EBITDA margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against ARM (11.3% ROE) versus MCHPP (12.6% ROE) capital efficiency.
In options market volatility and institutional positioning, ARM carries 90.6% implied volatility (73rd %ile, Elevated (60th–80th %ile)), a 1.91x (Put-Skewed) Put/Call open-interest ratio, NEUTRAL on-balance volume, and sits in a BREAKDOWN options structure phase (4.00β · 96% Vol realized risk). By comparison, MCHPP carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (2.16β · 65% Vol realized risk).
Cross-Compare 1-Click Peer Rivalries & Single-Stock Research
Microchip Technology Incorporated Depositary Shares Each Representing a 1/20th Interest in a Share of 7.50% Series A Mandatory Convertible Preferred Stock (MCHPP) Research Suite
Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 16, 2026. For educational research only; not investment advice.